Valuation: genedrive plc

Market Cap 20.87M 27.72M 24.33M 22.4M 39.36M 2.64B 40.16M 269M 104M 1.29B 104M 102M 4.5B P/E 2024
-0.35x
P/E 2025 -1.51x
Enterprise Value 19.69M 26.15M 22.96M 21.13M 37.13M 2.49B 37.89M 254M 98.47M 1.22B 98.17M 96.05M 4.25B EV / Sales 2024
7.57x
EV / Sales 2025 7.93x
Free-Float
36.5%
Yield 2024 *
-
Yield 2025 -
1 month-5.45%
3 months+36.84%
6 months+48.57%
Current year+48.57%
1 week 1.25
Extreme 1.25
1.5
1 month 1.1
Extreme 1.1
1.5
Current year 0.75
Extreme 0.75
1.5
1 year 0.19
Extreme 0.19
1.5
3 years 0.19
Extreme 0.19
18
5 years 0.19
Extreme 0.19
82
10 years 0.19
Extreme 0.19
302.6
Manager TitleAgeSince
Chief Executive Officer 56 2024-08-05
Director of Finance/CFO 48 2022-04-06
Director TitleAgeSince
Director/Board Member 52 2018-08-21
Director/Board Member 69 2018-04-08
Director/Board Member 56 2023-09-10
Date Insider Type Main position Quantity % Market Cap.
24-12-19Free 400,000 0.0736%
24-12-19Free 400,000 0.0736%
24-12-19Buy

Chief Executive Officer

1,135,208 0.2090%
Change 5-day change 1-year change 3-year change Capi.($)
0.00%0.00%-7.14%-92.57% 27.69M
-0.09%+4.56%+4.80%-27.66% 16.47B
+12.91%+8.53%+35.83%+90.87% 1.51B
+3.80%+48.89%-38.97%-78.06% 1.19B
+1.90%-0.06%-29.59%+28.31% 1.09B
+4.06%-4.19%-26.05%-53.14% 612M
+1.90%-0.30%-38.54%-55.88% 583M
+2.40%+2.99%+24.62%-54.69% 440M
+0.49%-3.16%-56.37%-61.35% 371M
+0.59%+0.15%-25.79%-25.38% 335M
Average +2.80%+6.06%-15.72%-32.95% 2.26B
Weighted average by Cap. +1.31%+6.63%-0.13%-22.24%

Financials

2024 2025
Net sales 501K 665K 584K 538K 945K 63.25M 964K 6.47M 2.51M 31.05M 2.5M 2.44M 108M 954K 1.27M 1.11M 1.02M 1.8M 120M 1.84M 12.31M 4.77M 59.12M 4.76M 4.65M 206M
Net income -7.08M -9.39M -8.25M -7.59M -13.34M -893M -13.61M -91.32M -35.38M -438M -35.27M -34.51M -1.53B -5.23M -6.95M -6.1M -5.61M -9.87M -660M -10.07M -67.52M -26.16M -324M -26.08M -25.52M -1.13B
Net Debt -5.17M -6.86M -6.03M -5.55M -9.75M -653M -9.95M -66.72M -25.85M -320M -25.77M -25.21M -1.11B -1.18M -1.57M -1.38M -1.27M -2.23M -149M -2.27M -15.26M -5.91M -73.25M -5.89M -5.77M -255M
Logo genedrive plc
genedrive plc is a United Kingdom-based pharmacogenetic testing company. The Company is engaged in developing and commercializing a rapid, versatile, simple to use and robust point-of-need pharmacogenetic platform for the diagnosis of genetic variations. The Company’s products include Genedrive MT-RNR1 ID Kit, Genedrive System, and Genedrive CYP2C19 ID Kit. The Company’s flagship product Genedrive MT-RNR1 ID Kit is a single-use disposable cartridge that circumvents the requirement for cold chain logistics by providing temperature stable reagent test kits for use on their proprietary test platform. The Genedrive System is a rapid thermocycler and signal detection system, enabling PCR and isothermal based amplification techniques. It is a semi- automated system used for qualitative in vitro molecular diagnostic tests. Its Genedrive CYP2C19 ID Kit Molecular point-of-care test for rapid CYP2C19 genotyping in time-critical emergency care settings.
Employees
43
Date Price Change Volume
26-07-01 GBX 1.300 0.00% 805,760
26-06-30 GBX 1.300 0.00% 3,309,027
26-06-29 GBX 1.300 0.00% 13,575,014
26-06-26 GBX 1.300 0.00% 2,312,953
26-06-25 GBX 1.300 0.00% 1,106,716

Annual profits - Rate of surprise